Search

Search Constraints

You searched for: Date 2022 Author/Creator Ferrara, R.

Search Results

1. 25P Platinum-based chemotherapy (PCT) addition to first-line PD-1/PD-L1 inhibitors (ICI) prevent hyperprogressive disease (HPD) in non-small cell lung cancer (NSCLC) patients (pts) by reducing circulating immature neutrophils. (December 2022)

2. Molecular characterization of primary and secondary resistance to RET inhibitors in patients with advanced NSCLC and RET fusions. (October 2022)